Ashkan Shoamanesh: Should Intracranial Hemorrhage Survivors with AFib Receive Anticoagulation?
Ashkan Shoamanesh, Associate Professor of Medicine (Neurology), Marta and Owen Boris Chair in Stroke Research and Care at McMaster University, shared on LinkedIn:
”Should intracranial hemorrhage (ICrH) survivors with atrial fibrillation receive anticoagulation?
If so: under which clinical circumstances?, after what time interval?, with what strategies to mitigate ICrH recurrence risk? and what is the level of supporting evidence?
These are common yet challenging questions in stroke practice, with many remaining unresolved.
We address them in detail in our recently published comprehensive review in the European Stroke Organisation Journal.”
Read the full article here.
Article: Oral Anticoagulation following intracranial haemorrhage in patients with atrial fibrillation
Authors: Ashkan Shoamanesh, Catharina JM Klijn, Kevin N Sheth, Roland Veltkamp, Else C Sandset, Charlotte Cordonnier, Rustam Al-Shahi Salman
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 25, 2025, 14:18From Ticagrelor to Prasugrel․ ISAR-REACT 5 Findings Redefine Clinical Practice
-
Nov 25, 2025, 12:03Ana Rita Rodrigues on Post-Stroke Oropharyngeal Dysphagia
-
Nov 25, 2025, 11:24Amy Goundry Takes on The Role of Managing Editor for Therapeutic Advances in Cardiovascular Disease
-
Nov 25, 2025, 11:01Jack Shuang Hou: Asundexian Hits Phase 3 Stroke Endpoint Without Increasing Bleeding Risk
-
Nov 25, 2025, 10:37Moin Makda: HemeNext Felt Like a Full Circle Moment
-
Nov 25, 2025, 10:14Lucas Di Meglio and Team Show That Targeting Extracellular DNA Mayy Reduce Microvascular Thrombosis
-
Nov 25, 2025, 09:54Hema Tallman on BioLife Plasma Services Leaders Spreading Holiday Cheer through Volunteerism
-
Nov 25, 2025, 09:36Stefan Hof on The Role of Pyrrolidine Dithiocarbamate in Hemorrhagic Shoke
-
Nov 25, 2025, 09:20Christian Schulze on The Role of TEE versus CT in the Detection of Left Atrial Thrombi